Xinchuo (Afatinib) 30mg Tablets | Jiangxi Shanxiang China | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Xinchuo (Afatinib) — Jiangxi Shanxiang, China

Xinchuo is a domestic Chinese generic of afatinib produced by Jiangxi Shanxiang Pharmaceutical Co., Ltd. This listing covers the 30 mg strength in a 7-tablet strip, the reduced-dose option for patients who need dose adjustment or have severe renal impairment. As a consistency-evaluated generic, Xinchuo offers the second-generation, irreversible EGFR inhibitor at an accessible price, widening treatment options for patients with EGFR-mutant non-small cell lung cancer.

What Is Xinchuo (Afatinib) Used For?

Xinchuo is used to treat non-small cell lung cancer with EGFR-activating mutations, including exon 19 deletions, the L858R substitution, and uncommon mutations such as G719X, L861Q and S768I. It is a first-line option for EGFR-mutant NSCLC and is also used in metastatic squamous NSCLC after progression on platinum-based chemotherapy. The 30 mg strength is commonly used for dose reduction or in patients with impaired renal function.

How Does Xinchuo (Afatinib) Work?

Xinchuo contains afatinib, an irreversible pan-ErbB tyrosine kinase inhibitor. It covalently binds EGFR, HER2 and ErbB4, permanently blocking the kinase signaling that EGFR-mutant lung cancer cells depend on for growth and survival. This irreversible mechanism delivers durable tumor control and covers uncommon EGFR mutations.

Indications

Xinchuo is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer with non-resistant EGFR mutations, and for metastatic squamous NSCLC progressing on or after platinum-based therapy. EGFR mutation testing is required before treatment.

Dosage

The standard afatinib dose is 40 mg once daily; the 30 mg strength is used for severe renal impairment or dose reduction for tolerability. Xinchuo 30 mg should be taken once daily on an empty stomach — at least one hour before or two hours after food. The 7-tablet strip is one week of therapy.

Side Effects

Common side effects of Xinchuo include diarrhea, acneiform rash, stomatitis, paronychia, dry skin and decreased appetite. Serious reactions such as interstitial lung disease, hepatotoxicity and severe skin disorders are uncommon but require prompt medical attention. Proactive management of diarrhea and skin symptoms is recommended.

Storage

Store Xinchuo in a cool, dry place away from sunlight and moisture, in its original packaging. Keep out of reach of children and swallow tablets whole with water.

Why Choose the GLT?

Xinchuo through GLT offers a consistency-evaluated domestic generic in the 30 mg strength, suited to patients who need a reduced dose or have kidney impairment. As a Hong Kong-licensed supplier, we source genuine stock and provide the documentation needed for confident purchasing. For those seeking an affordable, quality-assured 30 mg afatinib, Xinchuo is a practical choice.

How to Order Xinchuo (Afatinib)

Contact us on WhatsApp at +86 15234153837 or by email at [email protected] to order. Share your quantity and destination, and we will confirm availability, pricing and delivery.

FAQ

Who makes Xinchuo? Xinchuo is produced by Jiangxi Shanxiang Pharmaceutical Co., Ltd., a Chinese generic manufacturer.

Why choose the 30 mg strength? The 30 mg dose is used for patients with severe renal impairment or when a dose reduction is needed to improve tolerability.

Is Xinchuo equivalent to the originator? Yes, Xinchuo passed the national consistency evaluation, confirming bioequivalence to the originator afatinib.

Do I need a prescription? Yes, afatinib is a prescription oncology medicine used under physician supervision.

Related Oncology Products

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Barinat (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Natco Pharma Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Natco Pharma Limited (India) — an affordable alternative to Olumiant...

Avabopa (Avatrombopag) 20mg*30 Tablets | Tongmeng TLPH Laos | GLT

Avabopa — avatrombopag 20mg by Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), Lao Reg....

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland